Logo Image

Sponsored Videos

The Benefits of Tailored API Nanoparticles Webinar

ByNanoform

Learn about the benefits of tailored active pharmaceutical ingredient [API] nanoparticles in this webinar with Christopher P. Worrall, Ph.D. This presentation looks at how API nanoparticles enable patient-centric therapies and benefit many dosage forms, as well as how industry collaborations drive novel drug delivery approaches.

Behind CURIS System: A Gaseous Biodecontamination Solutions Provider

ByCURIS

CURIS® provides portable and fixed decontamination systems. CURIS® has revolutionized the biodecontamination world with efficacious hybrid hydrogen peroxide decontamination, which delivers a mix of vapor and micro-aerosols to each space at precisely calibrated intervals. Recent challenges in staffing for Life Sciences inspired CURIS® to help labs save time and money by creating a single system that completes multiple decontamination tasks in virtually any space, including as an integrated system for on-demand biodecontamination.

Energy Markets Volatility: The Rocky Road to Net Zero

According to the International Energy Agency, COVID-19 initially lead to a “staggering” decline in energy demand and depressed energy prices. Less than two years later, we are now faced with the cost of energy at an all-time high. Rapidly growing demand and, more recently, the Russian invasion of Ukraine, are driving energy prices to unprecedented highs and challenging security of supply. It is against this backdrop of uncertainty that we are simultaneously attempting to avert climate disaster through how we generate, store, use and manage energy. Should renewable or net zero carbon targets be postponed or is this all part of the rocky road to net zero?

The New Opportunity in Pharmaceutical Outsourcing: Portfolio Maintenance

ByPharmalex

For decades, the power and potential of outsourcing has been viewed as a way for pharmaceutical companies to gain access to specialized domain expertise across geographic regions and achieve cost savings amidst a highly complex and diverse regulatory environment. In the face of dwindling drug pipelines, complex regulations and block-busters crossing their patent exclusivity, mature products offer a revenue stream for companies to sustain their bottom lines in a hyper-competitive global market.

Tech Talks: Cell & Gene Therapy Series

ByPPD

Cell and gene therapies continue to expand rapidly, with an anticipated exponential growth over the next five years. This rapid growth has left an urgent need for industry scientists to gather and share lessons learned concerning bioanalytical, biomarker and regulatory strategies. This series provides insight from PPD Laboratories’ experts into a variety of cell and gene therapy (CGT) modalities in the bioanalytical community, with detailed discussions that leverage their experience with technologies and modalities within this CGT sphere.

Nanoform: Why Small Is Powerful

ByNanoform

Nanoform’s Eric Peter talks about what Nanoform showcased at AAPS 2021and what makes Nanoform’s particle engineering solutions unique.

The Advantages of Outsourcing Analytical Services

ByLGM Pharma

Dr. Prasad Raje, CEO of LGM Pharma, explores the importance of investing in robust analytical testing services, how pharma companies can leverage contract analytical services to save on costs and reduce development times, and more.